Special Considerations in the Management of Women With HIV, Including Management of Conception and Pregnancy

  • Author: Sigal Yawetz, MD (More Info)
  • Section Editor: Judith S. Currier, MD, MSc
  • Editors in Chief: Joseph J. Eron, Jr., MD; Daniel R. Kuritzkes, MD
  • Last Reviewed: 10/25/21 (What's New)

Summary

  • IV zidovudine near delivery is recommended for pregnant women with HIV-1 RNA > 1000 copies/mL or unknown HIV-1 RNA levels unless there is evidence of resistance or toxicity (Management Guidelines)[DHHS Perinatal]
  • Neonatal ART prophylaxis is also recommended:[DHHS Perinatal]
    • Full-term infants whose mother received a suppressive ART regimen during pregnancy: zidovudine for 4 weeks
  • Mode of Delivery
      Concurrent Antiretroviral Therapy and Other Medications

      Action required